Provider profile · Clinic-based weight management

Tri Valley Plastic Surgery review: services, costs, and questions

A Dublin, California practice publishes separate semaglutide and tirzepatide prices, monthly follow-up plans and virtual-consultation access. The exact prescription and complete financial terms still need confirmation.

Tri Valley Plastic Surgery source-reading diagram separating offer, care access and billing questions
Original editorial diagram based on public sources checked October 15, 2026.

Tri Valley Plastic Surgery presents GLP-1 weight management alongside its surgical and med-spa services in Dublin, California. The practice’s public pages name Steven Williams, MD, as overseeing its semaglutide program. This is the practice’s description, not our independent review of a clinician’s license or treatment quality.

Its published prices make an initial comparison possible, but an ingredient name does not identify the exact dispensed product. This review separates the first-month medication price, consultation fee, later monthly price and package questions using the provider pages checked October 15, 2026. We did not enroll or purchase treatment.

Evidence boundary: This is a review of public information, not a hands-on treatment assessment. We have not independently audited pharmacies, clinician credentials, response times, or patient outcomes. We do not assign a star rating.

What the official information says

The semaglutide page describes a consultation with a physician assistant, a medical-history assessment and monthly follow-ups. It says medication may be available at the visit if appropriate, which is conditional rather than a same-day prescription guarantee.

The same page offers virtual and in-person consultations in Dublin. That does not establish nationwide prescribing, remote-only treatment or shipping to every state. The tirzepatide page separately describes an initial health assessment and monthly monitoring.

Pricing and the full bill

The semaglutide FAQ lists a $50 initial consultation and medication at $500 for the first month, then $600 for subsequent months. The tirzepatide FAQ lists $700 for the first month and $800 afterward. Both mention four- and seven-month packages without establishing their total upfront payments. Financing is offered, but approval, repayment costs, lab charges and other inclusions need a written quote. The semaglutide consultation fee should not automatically be applied to the separate tirzepatide offer.

A first-month price is not a reliable annual budget. Ask for the amount charged today, the renewal interval, the cost after any promotion, and whether medication, supplies, visits, labs, and shipping are included. Obtain cancellation and refund terms before paying, particularly if a prescription has not yet been approved.

Limitations that affect your decision

The reviewed program pages name semaglutide and tirzepatide but do not establish the brand, compounded status or dispensing pharmacy for a selected prescription. A broad statement that an ingredient is FDA-approved cannot confirm that the product supplied to a patient is an approved branded medicine.

The website discusses possible cardiovascular and other health benefits. Product labels and studied populations matter; its broader cancer-risk language does not establish that this clinic’s program prevents cancer. Surgical testimonials and general practice ratings also do not establish GLP-1 outcomes.

Medication trials evaluate specific formulations, doses, and study populations. A provider advertising semaglutide or tirzepatide has not thereby demonstrated that its own treatment produces the results of Wegovy or Zepbound trials. A compounded medicine is not FDA-approved and should not be described as an approved generic equivalent.

Questions to ask before enrollment

  • Which exact branded or compounded product and pharmacy does the quoted program use?
  • What does the consultation, medication and follow-up total include, and are labs or supplies extra?
  • What is charged upfront for a four- or seven-month package, and what is refundable if treatment changes?
  • Which visits can be virtual, and in which state must I be located?
  • What notice stops future charges, and what happens to an order already sent to a pharmacy?

Ask the prescribing clinician how your other medicines, diabetes treatment, pregnancy plans, gastrointestinal history, and follow-up needs affect eligibility. Check the dispensing pharmacy with the relevant state board. A reassuring website or testimonial does not replace those checks.

Plan around the actual clinic and follow-up schedule

The practice lists Dublin Boulevard locations in Dublin. Confirm the appointment address for the weight-management service rather than assuming a surgical or med-spa location handles every visit. Virtual consultation availability can make an initial conversation easier without resolving examination, laboratory or dispensing requirements.

Monthly follow-up is the advertised care structure. Ask which clinician reviews symptoms between visits, how refills are authorized and how to obtain urgent clinical help. We have not measured the practice’s response time, dispensing speed or continuity of care.

A package and financing need their own written agreement

The four- and seven-month references do not explain whether every payment is collected at enrollment, whether medication is supplied in stages or how a clinician-directed stop affects unused services. Obtain those details before calculating a monthly equivalent or comparing a package with a recurring plan.

The accessible website terms address use of the site, not a complete GLP-1 cancellation, renewal or refund agreement. They do not establish the patient financial policy for an unfilled prescription, a late appointment cancellation or an unused package. Keep the applicable signed agreement with the quote.

Keep medication care separate from aesthetic services

A practice offering body contouring and post-weight-loss procedures may discuss those options, but they are separate clinical and financial decisions. A medication program does not make a cosmetic procedure necessary or prove that its benefits exceed its risks for an individual.

Our review covers public service descriptions and stated prices. It does not assign a care-quality score, verify patient testimonials or apply branded-drug trial results to an unidentified prescription. Resolve the product identity and care plan with the prescriber before relying on either a health-benefit claim or a package promotion.

Sources and evidence

Provider sources support advertised services and terms. Clinical and regulatory sources explain medication and pharmacy considerations. These are distinct kinds of evidence.

  1. Tri Valley: semaglutide program and price FAQ
  2. Tri Valley: tirzepatide program and price FAQ
  3. Tri Valley: practice and locations
  4. Tri Valley: website terms
  5. FDA concerns with unapproved GLP-1 drugs used for weight loss
  6. FDA clarification of compounding policies as GLP-1 supply stabilizes